|
⚲
|
| Keyboard |
| Sweet Chemistry Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002138153 |
| Sale | 2026-04-10 (1.6 M Offered, 1.6 M Sold) |
| Fund | |
| Phone | 2129294848 |
| Address | 455 West 22nd Street New York, NY 10011 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-06-25 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Andrea Nye | Director | |
| Kenneth Suslow | Director | |
| Joel Maza | Executive Officer | |
| Alec Batis | Promoter |
| Comparable Firms | State | AUM |
|---|---|---|
|
Thirty Seven Capital Management LP
✚
|
NY | |
|
EM Advisor LLC
✚
|
NY | |
|
Stratome Capital Management LP
✚
|
NY | |
|
RS Advisory Group LLC
✚
|
NY | |
|
Barlow Partners Inc
✚
|
NY | |
|
Fore Research and Management LP
✚
|
NY | |
|
Saltoun Capital Partners Management LLC
✚
|
NY | |
|
Warburg Pincus & Co
✚
|
NY | |
|
AQM Capital LLC
✚
|
NY | |
|
Aquamarine Capital Management LLC
✚
|
NY |